CHLA-42 (Q54812498)

From Wikidata

Jump to navigation Jump to search

cell line

CHLA_42

Language	Label	Description	Also known as
English	CHLA-42	cell line	CHLA_42

Statements

1 reference

Cellosaurus release 44

7 January 2023

cancer cell line

1 reference

Cellosaurus release 44

7 January 2023

described by source

Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.

1 reference

Cellosaurus release 44

7 January 2023

Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma

1 reference

Cellosaurus release 44

7 January 2023

Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma

1 reference

Cellosaurus release 44

7 January 2023

Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations

1 reference

Cellosaurus release 44

7 January 2023

established from medical condition

1 reference

Cellosaurus release 44

7 January 2023

derived from organism type

unknown value

1 reference

Cellosaurus release 44

7 January 2023

Identifiers

1 reference

Cellosaurus release 44

7 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54812498&oldid=1861200360"